149 related articles for article (PubMed ID: 18753946)
1. Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology.
Sullivan LM; Smolkin ME; Frierson HF; Galgano MT
Am J Surg Pathol; 2008 Nov; 32(11):1608-12. PubMed ID: 18753946
[TBL] [Abstract][Full Text] [Related]
2. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
[TBL] [Abstract][Full Text] [Related]
4. Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.
Park KJ; Bramlage MP; Ellenson LH; Pirog EC
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):8-11. PubMed ID: 18776815
[TBL] [Abstract][Full Text] [Related]
5. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
Gaggero G; Sola S; Mora M; Fulcheri E
Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
[TBL] [Abstract][Full Text] [Related]
6. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
Kaimaktchiev V; Terracciano L; Tornillo L; Spichtin H; Stoios D; Bundi M; Korcheva V; Mirlacher M; Loda M; Sauter G; Corless CL
Mod Pathol; 2004 Nov; 17(11):1392-9. PubMed ID: 15205684
[TBL] [Abstract][Full Text] [Related]
7. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
[TBL] [Abstract][Full Text] [Related]
8. CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma.
Saad RS; Ismiil N; Dubé V; Nofech-Mozes S; Khalifa MA
Am J Clin Pathol; 2009 Oct; 132(4):531-8. PubMed ID: 19762530
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
[TBL] [Abstract][Full Text] [Related]
10. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
11. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
12. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
13. Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
Giannico GA; Gown AM; Epstein JI; Revetta F; Bishop JA
Hum Pathol; 2017 Sep; 67():152-159. PubMed ID: 28711650
[TBL] [Abstract][Full Text] [Related]
14. Expression of CDX-2 and Ki-67 in different grades of colorectal adenocarcinomas.
Sen A; Mitra S; Das RN; Dasgupta S; Saha K; Chatterjee U; Mukherjee K; Datta C; Chattopadhyay BK
Indian J Pathol Microbiol; 2015; 58(2):158-62. PubMed ID: 25885126
[TBL] [Abstract][Full Text] [Related]
15. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
Werling RW; Yaziji H; Bacchi CE; Gown AM
Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886
[TBL] [Abstract][Full Text] [Related]
16. Cervical adenocarcinoma: a retrospective clinicopathologic study of 16 cases.
Barbu I; Crăiţoiu S; Mărgăritescu C
Rom J Morphol Embryol; 2012; 53(3):615-24. PubMed ID: 22990556
[TBL] [Abstract][Full Text] [Related]
17. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites.
De Lott LB; Morrison C; Suster S; Cohn DE; Frankel WL
Arch Pathol Lab Med; 2005 Sep; 129(9):1100-5. PubMed ID: 16119980
[TBL] [Abstract][Full Text] [Related]
18. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
McCluggage WG; Sumathi VP; McBride HA; Patterson A
Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
[TBL] [Abstract][Full Text] [Related]
19. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract].
Yue C; Piao Y; Bai Y; Liu H; Zhang L
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2447-50. PubMed ID: 26711206
[TBL] [Abstract][Full Text] [Related]
20. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F
Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]